Mantle cell lymphoma screening: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Farima Kahe (talk | contribs) No edit summary |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ Mantle cell lymphoma }} | {{Mantle cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{Akram}} {{AS}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for Mantle cell lymphoma. | |||
==Screening== | |||
There is insufficient evidence to recommend routine screening for Mantle cell lymphoma. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 05:04, 3 January 2019
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma screening On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma screening |
Risk calculators and risk factors for Mantle cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Sowminya Arikapudi, M.B,B.S. [3]
Overview
There is insufficient evidence to recommend routine screening for Mantle cell lymphoma.
Screening
There is insufficient evidence to recommend routine screening for Mantle cell lymphoma.